Inhibitors of tyrosine kinases in the treatment of psoriasis.
Ben-Bassat
H
H
Laboratory of Experimental Surgery, Hadassah University Hospital, Jerusalem, Israel. BenBassat@hadassah.org.il
Levitzki
A
A
D016923:Cell Death / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000145:classification / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D020032:Tyrphostins / Q000145:classification / Q000627:therapeutic use*
D003879:Dermatologic Agents; D004791:Enzyme Inhibitors; D020032:Tyrphostins; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases